Instem plc Trading Update (2209U)
December 24 2012 - 2:00AM
UK Regulatory
TIDMINS
RNS Number : 2209U
Instem plc
24 December 2012
24 December 2012
Embargoed for 07:00
Instem plc
("Instem", the "Company" or the "Group")
Trading Update
Instem plc (AIM: INS), a leading provider of IT solutions to the
global early development healthcare market, today provides an
update on trading in the year ending 31 December 2012.
Further to recent announcements, a number of contracts required
to meet revenue and profit expectations for the year remain
pending. Their ability to contribute to current year results will
only be known definitively at the year-end; accordingly Instem now
intends to announce its planned trading update in early
January.
For further information, please contact:
Instem plc +44 (0) 1785 825 600
Phil Reason, CEO
Nigel Goldsmith, CFO
N+1 Singer (Nominated Adviser &
Broker) +44 (0) 20 7496 3000
Aubrey Powell
Joe Stroud
Newgate Threadneedle +44 (0) 20 7653 9850
Caroline Evans-Jones
Fiona Conroy
About Instem plc
Instem is a leading supplier of IT solutions to the early
development healthcare market. Instem's pre-clinical study
management solutions accelerate drug and chemical development by
increasing productivity, automating processes and enhancing
practices that lead to safer and more effective drugs.
Instem has over 130 customers in North America, Europe, China,
India and Japan, including 16 of the top 20 pharmaceutical and
biotech companies such as GlaxoSmithKline and AstraZeneca. The
Group employs over 110 people in seven offices in the US, UK, China
and India; and has a full service distributor in Japan. It is
estimated that approximately half of the world's pre-clinical drug
safety data has been collected over the last 20 years via Instem
software, making Instem an ideal partner to help unlock the
scientific/commercial value from these legacy repositories.
To learn more about Instem please visit the Company's website,
www.instem.com, or its investor centre
http://investors.instem.com/
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTLFFSIFILVFIF
Instem (LSE:INS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Instem (LSE:INS)
Historical Stock Chart
From Jul 2023 to Jul 2024